Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Lyon Street Capital Is Extremely Bullish on These Five Stocks

Page 1 of 2

Brian C. Freckmann‘s Lyon Street Capital uses a bottom-up stock picking approach to identify value stocks in the small-cap, mid-cap, and large-cap space. The market value of the fund’s public equity portfolio stood at $137.87 million at the end of September. We decided to take a closer look at the firm’s top bets, which include GTT Communications Inc (NYSE:GTT), Atlas Financial Holdings Inc (NASDAQ:AFH), Grand Canyon Education Inc (NASDAQ:LOPE), Natus Medical Inc (NASDAQ:BABY), and Herbalife Ltd. (NYSE:HLF).

stocks, analysis, market, numbers, business, ticket, trade, money, price


Hedge funds have been underperforming the market for a very long time. However, this was mainly because of the huge fees that hedge funds charge as well as the poor performance of their short books. Hedge funds’ long positions performed actually better than the market. Small-cap stocks, activist targets, and spin offs were among the bright spots in hedge funds’ portfolios. For instance, the 15 most popular small-cap stocks among hedge funds outperformed the market by more than 53 percentage points since the end of August 2012 (read the details here). This strategy also managed to beat the market by double digits annually in our back tests covering the 1999-2012 period.

Brian C. Freckmann
Brian C. Freckmann
Lyon Street Capital

#5 Herbalife Ltd. (NYSE:HLF)

Shares held (as of September 30): 110,326

Total Value (as of September 30): $6.01 million

Percent of Portfolio (as of September 30): 4.36%

By almost doubling its Herbalife Ltd. (NYSE:HLF) holding in the third quarter we know which side of the Carl Icahn and Bill Ackman battle is Lyon Street on. Judging by the 43.79% surge  in the company’s stock price since the beginning of this year, many would have dispelled the belief that Herbalife is, as Ackman puts it, a Ponzi scheme. Although the $5.07 billion maker of nutritional products delivered a third quarter EPS of $1.28, handily beating estimates by $0.23, quarterly revenues of $1.1 billion came in $50 million lighter than expectations. The famous activist investor Carl Icahn‘s Icahn Capital LP held 17 million shares of Herbalife Ltd. (NYSE:HLF) at the end of the June trimester.

Follow Herbalife Ltd. (NYSE:HLF)
Trade (NYSE:HLF) Now!

#4 Natus Medical Inc (NASDAQ:BABY)

Shares held (as of September 30): 175,068

Total Value (as of September 30): $6.91 million

Percent of Portfolio (as of September 30): 5.01%

During the September quarter Lyon increased its stake in the provider of newborn care and neurology healthcare products and services by 21%. So far this year the stock has risen by a staggering 30%. Roth Capital recently reiterated its ‘Buy’ rating on the company and increased the price target to $53 from $51, which provides an upside of about 13% to the current trading levels. The company not only beat both the top and bottom line estimates in its financial results for the third trimester, but also raised guidance for the fiscal year 2015. Revenues are now expected in the $378 million – $381 million range as compared with the earlier estimate of $376 million – $378 million, while the estimates for Non-GAAP EPS have climbed to the range of $1.51 to $1.53 from $1.50 to $1.52. Ric Dillon‘s Diamond Hill Capital tops our list of Natus Medical Inc (NASDAQ:BABY)’s stockholders as it owned about 958,306 shares of the company at the end of September.

Follow Natus Medical Inc (NASDAQ:BABY)
Trade (NASDAQ:BABY) Now!

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!